Загрузка...
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
AIMS/HYPOTHESIS: Animal models of diabetic nephropathy show increased levels of glomerular vascular endothelial growth factor (VEGF)-A, and several studies have shown that inhibiting VEGF-A in animal models of diabetes can prevent albuminuria and glomerular hypertrophy. However, in those studies, tr...
Сохранить в:
| Опубликовано в: : | Diabetologia |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5552850/ https://ncbi.nlm.nih.gov/pubmed/28620823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4322-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|